Drugs / MK0533
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00543959 | Jun 2006 → Aug 2007 | type 2 diabetes mellitus | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK0533 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00543959 ↗ |
| Modality | Small molecule | — CHEMBL490029 ↗ |
| Target | PPARG | “Peroxisome proliferator-activated receptor gamma modulator” CHEMBL490029 ↗ |